NCT07205120 Fluid Guided Heart Failure Treatment at the Cleveland Clinic
| NCT ID | NCT07205120 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Bodyport Inc. |
| Condition | Heart Failure |
| Study Type | INTERVENTIONAL |
| Enrollment | 50 participants |
| Start Date | 2025-10-08 |
| Primary Completion | 2026-03 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 50 participants in total. It began in 2025-10-08 with a primary completion date of 2026-03.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
FIGHT-HF is an exploratory non-randomized open-label study evaluating a heart failure management intervention. The goal of this pilot is to assess the performance of a fluid-guided heart failure management program and Alert Response Guide (ARG) using the Bodyport Cardiac Scale and Congestion Index in 50 adult participants with acute and chronic heart failure, who are followed by a Cleveland Clinic cardiologist.
Eligibility Criteria
Inclusion Criteria: * Hospitalized for acute decompensated heart failure * Age 21 years or older * Able to speak and read English Exclusion Criteria: * New York Heart Association functional class IV symptoms * Received or are scheduled to receive a heart transplant or ventricular assist - device in the next 12 months * Have a glomerular filtration rate of less than 25 mL/min while nonresponsive to diuretic therapy or on chronic renal dialysis * Have a history of regularly scheduled intravenous HF therapy (e.g., inotropes or diuretics) * Have a life expectancy of less than 12 months * Are pregnant or plan to become pregnant during the next 12 months * Weigh greater than 375 lbs * Unable to stand on two bare feet without assistance
Frequently Asked Questions
Who can join the NCT07205120 clinical trial?
This trial is open to participants of all sexes, aged 21 Years or older, studying Heart Failure. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07205120 currently recruiting?
Yes, NCT07205120 is actively recruiting participants. Visit ClinicalTrials.gov or contact Bodyport Inc. to inquire about joining.
Where is the NCT07205120 trial being conducted?
This trial is being conducted at Cleveland, United States.
Who is sponsoring the NCT07205120 clinical trial?
NCT07205120 is sponsored by Bodyport Inc.. The trial plans to enroll 50 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.